Psychological Predictors of PDE5 Inhibitors in Vasculogenic Erectile Dysfunction

被引：0
|
作者：
Palmas, Artur [1 ]
Pascoal, Patricia [1 ]
Nobre, Pedro [2 ]
机构：
[1] Univ Porto, Doctoral Program Human Sexual, Porto, Portugal
[2] Univ Porto, Fac Psychol & Educ Sci, Ctr Psychol, Res Grp Human Sexual, Porto, Portugal
来源：
INTERNATIONAL JOURNAL OF SEXUAL HEALTH | 2019年 / 31卷
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：A568 / A568
页数：1
相关论文
共 50 条
  • [31] Improving Symptoms in Young Men with Erectile Dysfunction: Testosterone Therapy With or Without PDE5 Inhibitors
    Song, J.
    Saffati, G.
    Naeem, T.
    Biles, B.
    Pierce, H.
    Lipshultz, L., I
    Khera, M.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [32] Physical Activity and PDE5 Inhibitors in the Treatment of Erectile Dysfunction: Results of a Randomized Controlled Study
    Maio, Giuseppe
    Saraeb, Salim
    Marchiori, Antonio
    [J]. JOURNAL OF SEXUAL MEDICINE, 2010, 7 (06): : 2201 - 2208
  • [33] Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction
    Bi, YZ
    Stoy, P
    Adam, L
    He, B
    Krupinski, J
    Normandin, D
    Pongrac, R
    Seliger, L
    Watson, A
    Macor, JE
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (06) : 1577 - 1580
  • [34] Comparison of clinical efficacy and preference of three different PDE5 inhibitors for patients with erectile dysfunction
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 139 - 139
  • [35] Should physicians prescribe PDE5 inhibitors to sexually healthy males without erectile dysfunction?
    Gruenwald, I
    Appel, B.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E702 - U496
  • [36] Vardenafil improves satisfaction in couples affected by erectile dysfunction previously untreated with PDE5 inhibitors
    不详
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 177 - 177
  • [37] Substituted pyrazolopyridines as potent and selective PDE5 inhibitors: Potential agents for treatment of erectile dysfunction
    Yu, GX
    Mason, HJ
    Wu, XM
    Wang, J
    Chong, SH
    Dorough, G
    Henwood, A
    Pongrac, R
    Seliger, L
    He, B
    Normandin, D
    Adam, L
    Krupinski, J
    Macor, JE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (07) : 1025 - 1027
  • [38] Quinazolines as potent and highly selective PDE5 inhibitors as potential therapeutics for male erectile dysfunction
    Kim, Young Hoon
    Choi, Hojin
    Lee, Jaekwang
    Hwang, In-Chang
    Moon, Seung Kee
    Kim, Soo Jin
    Lee, Hong Woo
    Im, Dai Sig
    Lee, Sung Sook
    Ahn, Soon Kil
    Kim, Sang Woong
    Han, Cheol Kyu
    Yoon, Jeong Hyeok
    Lee, Kyung Joo
    Choi, Nam Song
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (23) : 6279 - 6282
  • [39] WHAT IS THE OVERALL SAFETY AND EFFICACY OF INHIBITORS OF THE PHOSPHODIESTERASE TYPE 5 ENZYME (PDE5) IN THE TREATMENT OF ERECTILE DYSFUNCTION?
    Ezquer, A. J.
    Gilli, F. A.
    Cenice, F. F.
    [J]. JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 89 - 89
  • [40] Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil
    Moncada, I.
    Martinez-Salamanca, J.
    Ruiz-Castane, E.
    Romero, J.
    [J]. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2018, 30 (05) : 203 - 208
12345